• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ORINF:US

36.1300 USD 1.3200 3.52%

As of 20:10:00 ET on 07/28/2014.

Snapshot for Orion OYJ (ORINF)

Open: 36.1300 Day's Range: 36.1300 - 36.1300 Volume: 410
Previous Close: 37.4500 52wk Range: 25.0000 - 37.4500 1-Yr Rtn: -

Stock Chart for ORINF

No chart data available.
  • ORINF:US 36.1300
  • 1D
  • 1M
  • 1Y
37.4500
Interactive ORINF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ORINF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 18.3780
Relative P/E vs. SPX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) 1.4990
Est. PEG Ratio -
Market Cap (M USD) 5,449.83
Shares Outstanding (M) 99.89
30 Day Average Volume 14
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 4.77%
Cash Dividend (EUR) 1.2500
Dividend Ex-Date 03/26/2014
5 Year Dividend Growth 6.10%
Next Earnings Announcement 10/22/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ORINF

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for ORINF

Orion Oyj develops and manufactures pharmaceuticals and diagnostic kits. The Company produces hormone therapies and drugs to treat central nervous system disorders, cardiovascular diseases and urological disorders, and in vitro diagnostic kits used in doctor's offices and small laboratories.

Hannu SyrjaenenChairmanJukka YlppoVice Chairman
Timo LappalainenPresident/CEOJari KarlsonChief Financial Officer
More Company Profile & Key Executives for ORINF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil